Effects of psilocybin-assisted therapy on treatment-resistant depression
European Psychiatry April 1, 2021 A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira et al. 1 citation
Introduction Major depressive disorder is a highly prevalent clinical condition, affecting more than 300 million individuals worldwide. About 1/3 of patients with MDD fail to achieve remission despite treatment with multiple antidepressants and are considered to have treatment-resistant depression (TRD). Novel antidepressants with rapid and sustained effects on mood and cognition could...